Publicaciones (340) Publicaciones de FERNANDO FERNÁNDEZ-LLIMÓS SOMOZA Ver datos de investigación referenciados.

2024

  1. Clinical pharmacy key performance indicators for hospital inpatient setting: a systematic review

    International Journal of Clinical Pharmacy, Vol. 46, Núm. 3, pp. 602-613

  2. Correction to: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ (International Journal of Clinical Pharmacy, (2023), 45, 4, (999-1006), 10.1007/s11096-023-01612-x)

    International Journal of Clinical Pharmacy

  3. Correction to: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies (DARU Journal of Pharmaceutical Sciences, (2023), 31, 1, (51-68), 10.1007/s40199-023-00461-3)

    DARU, Journal of Pharmaceutical Sciences

  4. Data quality review of the Brazilian nosocomial infections surveillance system

    Journal of Infection and Public Health, Vol. 17, Núm. 4, pp. 687-695

  5. Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study

    International Journal of Clinical Pharmacy, Vol. 46, Núm. 2, pp. 411-420

  6. Effect of T2-T4 sympathicotomy in skin temperature of pediatric patients with hyperhidrosis: a thermographic follow-up

    Clinical Autonomic Research

  7. Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study

    International Journal of Clinical Pharmacy, Vol. 46, Núm. 3, pp. 623-630

  8. Empowering pharmacists working in primary care through a cardiovascular disease clinical management course: Impact on practice

    Currents in Pharmacy Teaching and Learning, Vol. 16, Núm. 8

  9. Evaluation of Medical Subject Headings assignment in simulated patient articles

    International Journal of Pharmacy Practice, Vol. 32, Núm. 5, pp. 396-404

  10. Impact of COVID-19 on tuberculosis notifications

    Revista do Instituto de Medicina Tropical de Sao Paulo, Vol. 66, pp. e37

  11. Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping

    Addiction Science and Clinical Practice, Vol. 19, Núm. 1

  12. Impact of the COVID-19 pandemic on antidepressant consumption in the Central region of Portugal: interrupted time series

    Social Psychiatry and Psychiatric Epidemiology

  13. Influence of automated indexing in Medical Subject Headings (MeSH) selection for pharmacy practice journals

    Research in Social and Administrative Pharmacy, Vol. 20, Núm. 9, pp. 911-917

  14. Mapping the concept of health care integration: A lexicographic analysis of scientific literature

    Research in Social and Administrative Pharmacy, Vol. 20, Núm. 5, pp. 506-511

  15. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

    Revista Portuguesa de Cardiologia

  16. Theories, models and frameworks for health systems integration. A scoping review

    Health Policy, Vol. 141

  17. Variability in Drug Procurement within Group 1B of the Pharmaceutical Specialized Scheme in Brazil

    Ciencia e Saude Coletiva, Vol. 29, Núm. 1

2023

  1. A Universal Pharmacological-Based List of Drugs with Anticholinergic Activity

    Pharmaceutics, Vol. 15, Núm. 1

  2. Chemical Constituents, Anticancer and Anti-Proliferative Potential of Limonium Species: A Systematic Review

    Pharmaceuticals, Vol. 16, Núm. 2

  3. Comment on the article: “Peer review practices in academic medicine: how the example of orthopaedic surgery may help shift the paradigm?”

    International Orthopaedics